The M Care London desk: India-rooted supply, present in the UK.
M Care is an Indian WHO-GMP merchant exporter, and our London commercial desk puts that supply on the ground in the United Kingdom. It is the point of contact for UK hospital pharmacies, MHRA Specials (MS) licence holders and named-patient or unlicensed-import buyers who want an India-cost source with a UK presence behind it.
The UK, Europe and Commonwealth point of contact.
The London desk is M Care's commercial presence for the United Kingdom and the wider Commonwealth. It is the first response on a UK enquiry, the support line on MHRA Specials and named-patient import documentation, and a local presence when a buyer wants a face for a technical visit, audit support or a pre-tender briefing. The commercial routing and the WHO-GMP sourcing run through the Mumbai desk, so you get UK proximity without the order being handed across a call-centre queue.
Most of the buyers the London desk talks to are UK hospital pharmacies, MS (Specials) licence holders and specialist importers who already know the route they need and want a dependable source behind it. That is the lane M Care holds: the UK unlicensed-medicines and named-patient cluster, sourced from WHO-GMP product in India.
Both ends of the chain: an India source and a UK desk.
A pure UK wholesaler sells from UK-held stock at UK landed cost. A pure India exporter has the cost source but no UK presence and no feel for the MHRA Specials paperwork. M Care sits at both ends: direct WHO-GMP manufacturer relationships in India for the source, and a London desk that understands what a Responsible Person expects at goods-in. That source-plus-destination position is exactly why M Care ranks where it does on the UK MHRA-Specials and named-patient cluster, and it is a claim a single-country competitor structurally cannot make.
It also means honest limits. We do not hold a UK wholesale-dealer licence and we do not pretend to. The import of record is the buyer's licensed entity; M Care's job is the compliant supply, the documentation pack and the named accountability behind it. Our United Kingdom market page sets out the regulatory framing in full. For Gulf and East African supply, M Care runs a parallel Dubai desk.
Enquiry to UK goods-in, one accountable team.
You send the molecule, grade, volume and the UK use-case (an MS-licence Specials line, or a named-patient case). The Mumbai desk confirms the WHO-GMP source, price, lead time and the documentation position. The package ships with the records a UK Responsible Person expects: a batch Certificate of Analysis, the manufacturer's GMP certificate and licence, a Certificate of Pharmaceutical Product where required, and the cold-chain trail for temperature-sensitive lines. The London desk supports the UK-side handover. One named contact carries the order from first enquiry to delivery note.
UK presence, India sourcing, one accountable desk.
Is M Care a UK-licensed wholesaler?
No, and we never claim to be. M Care is a merchant exporter that sources WHO-GMP product from Indian manufacturers and exports it; the London desk is a commercial presence for UK and Commonwealth buyers, not an MHRA WDA(H) wholesale-dealer licence holder. Where a buyer needs UK-held stock or an MS licence, the import is received by the buyer's own licensed entity, and our role is the compliant supply and documentation behind it.
What does the London desk actually do?
It is the UK, Europe and Commonwealth point of contact: first response on enquiries, support on MHRA Specials and named-patient documentation, and a local presence for technical visits, audit support and pre-tender briefings. Commercial routing and sourcing run through the Mumbai desk, so the London desk gives you proximity without breaking the single accountable chain.
Why use an India-rooted exporter with a UK desk instead of a UK wholesaler?
Because you get both ends of the chain. A pure UK wholesaler sells from UK-held stock at UK prices; a pure India exporter has the cost source but no UK presence. M Care sits at the source (WHO-GMP manufacturer relationships in India) and at the destination (a London desk that understands the MHRA Specials and named-patient routes), which is why we hold the UK MHRA-Specials and named-patient niche.
Which UK routes does the London desk support?
Principally the unlicensed-medicines routes: MHRA Specials (Regulation 167 / the Specials exemption) supply into MS licence holders, and named-patient import where a specific clinical need cannot be met by a licensed product. See our detailed pages on named-patient import to the UK and MHRA Specials supply for how each route is documented.
Send the molecule and the UK use-case. The London desk replies within one working day.
Tell us the molecule, grade, volume and whether it is an MS-licence Specials line or a named-patient case. The Mumbai desk prices and sources it, the London desk supports the UK-side documentation and handover, and you get one named contact start to finish.
Start an enquiry → WhatsApp the desk